Humoral and cellular immune response elicited by two doses of mRNA BNT162b2 vaccine against SARS-CoV-2 in people living with HIV (PLWH)
Description
At present, whether SARS-CoV-2 vaccines can elicit robust humoral and cellular immune responses in people living with HIV (PLWH) is still controversial. We assessed humoral and cellular immune response after the administration of the BNT162b2-mRNA